Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-3-10
pubmed:abstractText
Chromatin remodeling such as changes in histone acetylation has been suggested to play an important role in the pathophysiology and treatment of mood disorders. In the present study, we investigated whether the expression of histone deacetylase (HDAC) genes are altered in mood disorder patients. We used quantitative real-time PCR to measure the mRNA levels of 11 HDACs (HDAC1-11) in peripheral white blood cells of major depressive disorder (MDD) and bipolar disorder (BPD) patients during depressive and remissive episodes and in the first-degree relatives of BPD patients. In addition, we investigated the effect of antidepressants and mood stabilizers on the mRNA levels of HDACs using mice. In MDD, the expression of HDAC2 and -5 mRNA was increased in a depressive state, but not in a remissive state, compared to controls. In BPD, the expression of HDAC4 mRNA was increased only in a depressive state, and the expression of HDAC6 and -8 was decreased in both depressive and remissive states compared to controls, whereas the first-degree relatives did not show any significant alteration in expression levels. Animal study showed that the expression of HDAC2 and -5 or HDAC4, -6 and -8 mRNAs in the mouse leukocytes were not affected by chronic treatment with antidepressants or mood stabilizers. Our data suggest that aberrant transcriptional regulation caused by the altered expression of HDACs is associated with the pathophysiology of mood disorders.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1879-1379
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
263-70
pubmed:meshHeading
pubmed-meshheading:19767015-Animals, pubmed-meshheading:19767015-Antidepressive Agents, pubmed-meshheading:19767015-Clomipramine, pubmed-meshheading:19767015-Corticotropin-Releasing Hormone, pubmed-meshheading:19767015-Dexamethasone, pubmed-meshheading:19767015-Disease Models, Animal, pubmed-meshheading:19767015-Female, pubmed-meshheading:19767015-Gene Expression Regulation, pubmed-meshheading:19767015-Histone Deacetylases, pubmed-meshheading:19767015-Humans, pubmed-meshheading:19767015-Hydrocortisone, pubmed-meshheading:19767015-Male, pubmed-meshheading:19767015-Mice, pubmed-meshheading:19767015-Mice, Inbred BALB C, pubmed-meshheading:19767015-Mice, Inbred C57BL, pubmed-meshheading:19767015-Middle Aged, pubmed-meshheading:19767015-Mood Disorders, pubmed-meshheading:19767015-Paroxetine, pubmed-meshheading:19767015-RNA, Messenger, pubmed-meshheading:19767015-Swimming
pubmed:year
2010
pubmed:articleTitle
Altered gene expression of histone deacetylases in mood disorder patients.
pubmed:affiliation
Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University, Graduate School of Medicine, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't